» Articles » PMID: 22797131

Monitoring Breathing Rate at Home Allows Early Identification of COPD Exacerbations

Abstract

Background: Respiratory frequency increases during exacerbations of COPD (ECOPD). We hypothesized that this increase can be detected at home before ECOPD hospitalization.

Methods: To test this hypothesis, respiratory frequency was monitored at home daily for 3 months in 89 patients with COPD (FEV₁, 42.3% ± 14.0%; reference) who were receiving domiciliary oxygen therapy (9.6 ± 4.0 h/d).

Results: During follow-up, 30 patients (33.7%) required hospitalization because of ECOPD. In 21 of them (70%), mean respiratory frequency increased (vs baseline) during the 5 days that preceded it (from 15.2 ± 4.3/min to 19.1 ± 5.9/min, P < .05). This was not the case in patients without ECOPD (16.1 ± 4.8/min vs 15.9 ± 4.9/min). Receiver operating characteristic analysis showed that 24 h before hospitalization, a mean increase of 4.4/min (30% from baseline) provided the best combination of sensitivity (66%) and specificity (93%) (area under the curve [AUC] = 0.79, P < .05). Two days before hospitalization, a mean increase of 2.3/min (15% change from baseline) was associated with a sensitivity of 72% and a specificity of 77% (AUC = 0.76, P < .05).

Conclusions: Respiratory frequency can be monitored daily at home in patients with COPD receiving domiciliary oxygen therapy. In these patients, breathing rate increases significantly days before they require hospitalization because of ECOPD. This may offer a window of opportunity for early intervention.

Citing Articles

Detection of COPD exacerbations with continuous monitoring of breathing rate and inspiratory amplitude under oxygen therapy.

Alves Pegoraro J, Guerder A, Similowski T, Salamitou P, Gonzalez-Bermejo J, Birmele E BMC Med Inform Decis Mak. 2025; 25(1):101.

PMID: 40001140 PMC: 11863910. DOI: 10.1186/s12911-025-02939-3.


Noncontact Longitudinal Respiratory Rate Measurements in Healthy Adults Using Radar-Based Sleep Monitor (Somnofy): Validation Study.

Toften S, Kjellstadli J, Thu O, Ellingsen O JMIR Biomed Eng. 2024; 7(2):e36618.

PMID: 38875674 PMC: 11041471. DOI: 10.2196/36618.


Remote patient monitoring strategies and wearable technology in chronic obstructive pulmonary disease.

Coutu F, Iorio O, Ross B Front Med (Lausanne). 2023; 10:1236598.

PMID: 37663662 PMC: 10470466. DOI: 10.3389/fmed.2023.1236598.


Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease.

Bhatt S, Agusti A, Bafadhel M, Christenson S, Bon J, Donaldson G Am J Respir Crit Care Med. 2023; 208(10):1026-1041.

PMID: 37560988 PMC: 10867924. DOI: 10.1164/rccm.202209-1748SO.


Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients.

Reumkens C, Endres A, Simons S, Savelkoul P, Sprooten R, Franssen F ERJ Open Res. 2023; 9(3).

PMID: 37228266 PMC: 10204729. DOI: 10.1183/23120541.00569-2022.